Mirra-Diovit - instructions for use, dose, composition, contraindications

Certificate number:RU.77.99.88.003.E.001392.03.16

Date of registration and renewal:29.03.2016

Dosage form: & nbsptablets weighing 500 mg

Classification "Composition" & nbsp Other dietary supplements

Classification "Clinical" & nbsp Supplements of various groups

Composition: & nbspBiologically active substances, mg / tab: succinic acid - 90 -110, dihydroquercetin - 4,75 - 5,5.

yeast autolysate, E460i, succinic acid, stevioside, dihydroquercetin, E470.

Scope: & nbspfor realization to the population as biologically active additive to food - a source of dihydroquercetin and succinic acid.

Suggested Usage: & nbspadults 1 tablet 2 times a day with meals. Duration of admission is 20 days.

Contraindications:individual intolerance of components, pregnancy, breast-feeding. Before use, it is recommended to consult a doctor.

Shelf life:2 years.

Storage conditions:Store in a dry place protected from direct sunlight at a temperature of no higher than 25 ° C.

Research protocols:expert conclusion of the FGBICU "NII Nutrition" №72 / Э-1532 / б-15 of 19.11.2015.

Manufacturers

Mirra-M, ZAO Russian Federation

ZAO Mirra-M, 105082, Moscow, Perevedenovsky per., 6, building 2 (address of production: 142279, Moscow region, Serpukhov district, Obolensk settlement, building 31) (Russian Federation)

Recipient:Mirra-M, ZAOMirra-M, ZAO Russian Federation

Information update date: & nbsp05.04.2016

Instructions